Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glycolytic Metabolism, Brain Resilience, and Alzheimer’s Disease
Xin Zhang, Nadine Alshakhshir, Liqin Zhao
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease
Eugenio Barone, Fabio Di Domenico, Marzia Perluigi, et al.
Free Radical Biology and Medicine (2021) Vol. 176, pp. 16-33
Open Access | Times Cited: 98
Hippocampal disruptions of synaptic and astrocyte metabolism are primary events of early amyloid pathology in the 5xFAD mouse model of Alzheimer’s disease
Jens V. Andersen, Niels H. Skotte, Sofie K. Christensen, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 11
Open Access | Times Cited: 65
Integrated multi-omics analysis of Alzheimer’s disease shows molecular signatures associated with disease progression and potential therapeutic targets
Pradeep Kodam, R. Sai Swaroop, Sai Sanwid Pradhan, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 39
Metabolic defects shared by Alzheimer's disease and diabetes: A focus on mitochondria
Cristina Carvalho, Paula I. Moreira
Current Opinion in Neurobiology (2023) Vol. 79, pp. 102694-102694
Open Access | Times Cited: 29
Hiding in Plain Sight: Modern Thiamine Deficiency
Chandler Marrs, Derrick Lonsdale
Cells (2021) Vol. 10, Iss. 10, pp. 2595-2595
Open Access | Times Cited: 49
The role of NURR1 in metabolic abnormalities of Parkinson’s disease
Murad Al‐Nusaif, Yuting Yang, Song Li, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 31
Neuroprotective Mechanisms of Puerarin in Central Nervous System Diseases: Update
Chao-Chao Yu, Yan-Jun Du, Jin Li, et al.
Aging and Disease (2022) Vol. 13, Iss. 4, pp. 1092-1092
Open Access | Times Cited: 30
Aberrant energy metabolism in Alzheimer’s disease
Linjie Yu, Jiali Jin, Yun Xu, et al.
Journal of Translational Internal Medicine (2022) Vol. 10, Iss. 3, pp. 197-206
Open Access | Times Cited: 29
New cyclophilin D inhibitor rescues mitochondrial and cognitive function in Alzheimer’s disease
Sourav Samanta, Firoz Akhter, Anuradha Roy, et al.
Brain (2023) Vol. 147, Iss. 5, pp. 1710-1725
Open Access | Times Cited: 20
Icariin ameliorates glycolytic dysfunction in Alzheimer's disease models by activating the Wnt/β‐catenin signaling pathway
Ju Liu, Ai‐Hong Wei, Tingting Liu, et al.
FEBS Journal (2024) Vol. 291, Iss. 10, pp. 2221-2241
Closed Access | Times Cited: 7
Lower GLUT1 and unchanged MCT1 in Alzheimer’s disease cerebrovasculature
Manon Leclerc, Cyntia Tremblay, Philippe Bourassa, et al.
Journal of Cerebral Blood Flow & Metabolism (2024) Vol. 44, Iss. 8, pp. 1417-1432
Open Access | Times Cited: 6
The role of microRNA-34 family in Alzheimer’s disease: A potential molecular link between neurodegeneration and metabolic disorders
Maryam Bazrgar, Pariya Khodabakhsh, Mercedes Prudencio, et al.
Pharmacological Research (2021) Vol. 172, pp. 105805-105805
Closed Access | Times Cited: 33
Vitamin B12 impacts amyloid beta-induced proteotoxicity by regulating the methionine/S-adenosylmethionine cycle
Andy B. Lam, Kirsten Kervin, Jessica E. Tanis
Cell Reports (2021) Vol. 36, Iss. 13, pp. 109753-109753
Open Access | Times Cited: 33
Monitoring and modelling the dynamics of the cellular glycolysis pathway: A review and future perspectives
Nitin Patil, Orla Howe, Paul A. Cahill, et al.
Molecular Metabolism (2022) Vol. 66, pp. 101635-101635
Open Access | Times Cited: 24
Opposing Effects of ApoE2 and ApoE4 on Glycolytic Metabolism in Neuronal Aging Supports a Warburg Neuroprotective Cascade against Alzheimer’s Disease
Xin Zhang, Long Wu, Russell H. Swerdlow, et al.
Cells (2023) Vol. 12, Iss. 3, pp. 410-410
Open Access | Times Cited: 15
Glymphatic System and Mitochondrial Dysfunction as Two Crucial Players in Pathophysiology of Neurodegenerative Disorders
Kamila Kopeć, Stanisław Szleszkowski, Dariusz Koziorowski, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10366-10366
Open Access | Times Cited: 15
Exploring glycolytic enzymes in disease: potential biomarkers and therapeutic targets in neurodegeneration, cancer and parasitic infections
Maura Rojas-Pirela, Diego Andrade-Alviárez, Verónica Rojas, et al.
Open Biology (2025) Vol. 15, Iss. 2
Open Access
Identification and Exploration of Immunity‐Related Genes and Natural Products for Alzheimer's Disease Based on Bioinformatics, Molecular Docking, and Molecular Dynamics
Pengpeng Liang, Chang Ye Yale Wang, J Liu, et al.
Immunity Inflammation and Disease (2025) Vol. 13, Iss. 4
Open Access
l-Lactate: Food for Thoughts, Memory and Behavior
María Fernanda Veloz Castillo, Pierre J. Magistretti, Corrado Calì
Metabolites (2021) Vol. 11, Iss. 8, pp. 548-548
Open Access | Times Cited: 27
Optimized sample preparation and data analysis for TMT proteomic analysis of cerebrospinal fluid applied to the identification of Alzheimer’s disease biomarkers
Sophia Weiner, Mathias Sauer, Pieter Jelle Visser, et al.
Clinical Proteomics (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 20
Metabolic Features of Brain Function with Relevance to Clinical Features of Alzheimer and Parkinson Diseases
D. Allan Butterfield, Maria Favia, Iolanda Spera, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 951-951
Open Access | Times Cited: 19
The unique neuropathological vulnerability of the human brain to aging
Isidró Ferrer
Ageing Research Reviews (2023) Vol. 87, pp. 101916-101916
Open Access | Times Cited: 11
Dopamine modification of glycolytic enzymes impairs glycolysis: possible implications for Parkinson’s disease
Bing Chen, Qian Zhang, Xiaoru Zhong, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Modulating Mitochondrial Dynamics Mitigates Cognitive Impairment in Rats with Myocardial Infarction
Kewarin Jinawong, Chanon Piamsiri, Nattayaporn Apaijai, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 10, pp. 1749-1760
Open Access | Times Cited: 4
Metabolic Imbalance in Immune Cells in Relation to Metabolic Disorders, Cancer, and Infections
Mahmoud Singer, Rania Hamdy, Jana H. Ghonaim, et al.
(2025), pp. 187-218
Closed Access
Page 1 - Next Page

Scroll to top